Chief Quality Operations Officer and Executive Vice President, Analytical Sciences and Research
John Pinion joined Ultragenyx in July 2015. Mr. Pinion is responsible for the overall quality operations and analytical sciences, including Quality management of all GxP, Compliance, Validation, QC GMP, QC Clinical and QC Research. Mr. Pinion also participates in translational research, business development, and strategic planning activities as a key member of Ultragenyx's executive leadership team.
Mr. Pinion has over 25 years of global experience providing executive leadership and expertise in quality and manufacturing management of biologic, pharmaceutical and device operations in Asia, Europe and the Americas. Mr. Pinion most recently served as SVP and Global Head of Quality and Compliance for Roche/Genentech Pharma Technical Operations, responsible for all Biotech and Pharmaceutical Quality and GMP compliance activities. He joined Genentech in 2005 as the Vice President of External Quality and was responsible for establishing domestic and international long-term strategies for external drug substance and drug product manufacturing as well as external drug development. He was promoted in 2007 to SVP and head of Quality and Compliance and later appointed Head of Quality and Compliance for Roche as a part of the integration.
Prior to joining Genentech in 2005, Mr. Pinion held several executive positions for Baxter Healthcare, including VP Quality, Renal, Cellular Therapies and Baxter Japan and VP Quality North American Operations, Baxter BioScience. In addition, he is currently serving as an independent board member for Aroa Biosurgery, located in Auckland, New Zealand.
John holds a B.S. in Mechanical Engineering from the University of West Virginia.